These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5466652)

  • 1. [Biochemistry of demyelinating diseases and myelin].
    Kurihara T
    Nihon Rinsho; 1970 Sep; 28(9):2185-8. PubMed ID: 5466652
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelin in normal and diseased states.
    Baumann N; Jacque C; Hauw JJ
    Neurol Clin; 1983 Aug; 1(3):701-27. PubMed ID: 6209539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxic nervous pathology: biochemistry of myelin and demyelinizing conditions].
    Baumann N
    Eur J Toxicol; 1972; 5(1):7-11. PubMed ID: 4647427
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipids in myelin membrane].
    Kishimoto Y; Okamura N
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1069-84. PubMed ID: 6396719
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in myelin biochemistry.
    Norton WT
    Ann N Y Acad Sci; 1984; 436():5-10. PubMed ID: 6398023
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelin lipids in cyanide encephalopathy.
    Wender M; Adamczewska Z; Pankrac J; Wajgt A
    Neuropatol Pol; 1978; 16(2):153-62. PubMed ID: 687390
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of phospholipids, particularly plasmalogens, in the demyelination of multiple sclerosis as compared with that of cerebral oedema.
    Yanagihara T; Cumings JN
    Brain; 1969 Mar; 92(1):59-70. PubMed ID: 5774032
    [No Abstract]   [Full Text] [Related]  

  • 8. Phospholipids in demyelinating diseases.
    Bukovský V; Dobrota D; Mézesová V
    Acta Univ Carol Med (Praha); 1987; 33(7-8):561-9. PubMed ID: 3455640
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the mechanism of demyelination. Regional differences in myelin stability in vitro.
    Smith ME; Sedgewick LM
    J Neurochem; 1975 Apr; 24(4):763-70. PubMed ID: 1123631
    [No Abstract]   [Full Text] [Related]  

  • 10. [The structure and chemistry of myelin (review of the literature)].
    Smirnova EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(7):1093-104. PubMed ID: 1108557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemistry of the myelin].
    Kurihara T
    Tanpakushitsu Kakusan Koso; 1969 Mar; 14(4):357-69. PubMed ID: 4893282
    [No Abstract]   [Full Text] [Related]  

  • 12. Polypeptides in cerebral myelin from normal humans and patients dying with multiple sclerosis.
    Moscarello MA; Lowden JA; Wood DD
    Neurology; 1968 Mar; 18(3):295. PubMed ID: 5690386
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fatty acid composition of glycerophospholipids in the brain of the growing rat during experimental demyelination].
    Bliudzin IuA; Zuber VL
    Nerv Sist; 1982; 23():125-9. PubMed ID: 7187938
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral lipid composition during myelination in murine genetic leukodystrophies.
    Hogan EL; Joseph KC
    Neurology; 1970 Apr; 20(4):416. PubMed ID: 5535077
    [No Abstract]   [Full Text] [Related]  

  • 15. Zonal centrifugation and flotation-fractionation of MSD mutant mouse brain.
    Day ED; Mickey DD; Rigsbee LC; Meier H
    J Neurobiol; 1972; 3(4):325-38. PubMed ID: 5087159
    [No Abstract]   [Full Text] [Related]  

  • 16. The lipid composition of pure myelin in some demyelinating disorders.
    Cumings JN
    Neuropatol Pol; 1969; 7(3):255-60. PubMed ID: 5370318
    [No Abstract]   [Full Text] [Related]  

  • 17. Histochemistry of myelin. 13. Digestion of basic protein outside acute plagues of multiple sclerosis.
    Adams CW; Hallpike JF; Bayliss OB
    J Neurochem; 1971 Aug; 18(8):1479-83. PubMed ID: 4106033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lessons learned by the study of myelination in mice mutants].
    Mandel P; Neskovic NM; Nussbaum JL
    C R Seances Soc Biol Fil; 1971; 165(3):474-91. PubMed ID: 4258227
    [No Abstract]   [Full Text] [Related]  

  • 19. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.
    Mastronardi FG; Mak B; Ackerley CA; Roots BI; Moscarello MA
    J Clin Invest; 1996 Jan; 97(2):349-58. PubMed ID: 8567954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelin antibodies].
    Aarli JA
    Tidsskr Nor Laegeforen; 1975 Sep; 95(26):1485-9. PubMed ID: 1179363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.